Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-01 4:15 pm Purchase | 2024-01-22 | 13G | ORIC Pharmaceuticals, Inc. ORIC | Venrock Healthcare Capital Partners III L.P. | 4,428,385 6.600% | 4,428,385 (New Position) | Filing History |
| 2024-01-02 4:16 pm Purchase | 2023-12-21 | 13G | Astria Therapeutics, Inc. ATXS | Venrock Healthcare Capital Partners III L.P. | 3,225,806 8.900% | 3,225,806 (New Position) | Filing History |
| 2023-12-28 4:17 pm Purchase | 2023-12-18 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III L.P. | 7,775,760 6.800% | 7,775,760 (New Position) | Filing History |
| 2023-12-28 4:16 pm Purchase | 2023-12-26 | 13G | KalVista Pharmaceuticals, Inc. KALV | Venrock Healthcare Capital Partners III L.P. | 3,573,714 10.300% | 657,047 (+22.53%) | Filing History |
| 2023-11-30 4:15 pm Purchase | 2023-11-20 | 13G | Pharvaris N.V. PHVS | Venrock Healthcare Capital Partners III L.P. | 2,483,606 6.100% | 2,483,606 (New Position) | Filing History |
| 2023-11-22 4:16 pm Purchase | 2023-10-24 | 13G | ABIVAX SA ABVX | Venrock Healthcare Capital Partners III L.P. | 3,313,000 5.300% | 3,313,000 (New Position) | Filing History |
| 2023-09-29 4:15 pm Purchase | 2023-09-19 | 13G | RayzeBio, Inc. Common Stock RYZB | Venrock Healthcare Capital Partners III L.P. | 4,016,847 6.600% | 4,016,847 (New Position) | Filing History |
| 2023-09-21 4:15 pm Purchase | 2023-09-11 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III L.P. | 927,706 6.300% | 927,706 (New Position) | Filing History |
| 2023-08-28 4:16 pm Purchase | 2023-08-16 | 13G | Taysha Gene Therapies, Inc. TSHA | Venrock Healthcare Capital Partners III L.P. | 14,444,444 7.700% | 14,444,444 (New Position) | Filing History |
| 2023-08-07 4:15 pm Purchase | 2023-07-28 | 13G | Mersana Therapeutics, Inc. MRSN | Venrock Healthcare Capital Partners III L.P. | 9,678,000 8.500% | 9,678,000 (New Position) | Filing History |
| 2023-07-28 4:15 pm Purchase | 2023-07-18 | 13D | Apogee Therapeutics, Inc. APGE | Venrock Healthcare Capital Partners III L.P. | 3,887,478 9.990% | 3,887,478 (New Position) | Filing History |
| 2023-07-24 4:16 pm Purchase | 2023-07-14 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III L.P. | 589,949 5.900% | 589,949 (New Position) | Filing History |
| 2023-07-10 4:16 pm Purchase | 2023-06-28 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Venrock Healthcare Capital Partners III L.P. | 319,200 9.990% | 319,200 (New Position) | Filing History |
| 2023-06-30 4:15 pm Purchase | 2023-06-21 | 13G | Praxis Precision Medicines, Inc. PRAX | Venrock Healthcare Capital Partners III L.P. | 823,627 9.110% | 823,627 (New Position) | Filing History |
| 2023-05-15 4:17 pm Purchase | 2023-05-05 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Venrock Healthcare Capital Partners III L.P. | 2,887,517 8.700% | 2,887,517 (New Position) | Filing History |
| 2023-05-08 4:05 pm Purchase | 2023-04-26 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III L.P. | 5,797,585 9.990% | 5,797,585 (New Position) | Filing History |
| 2023-03-13 4:01 pm Purchase | 2023-03-03 | 13G | Enliven Therapeutics, Inc. ELVN | Venrock Healthcare Capital Partners III L.P. | 2,214,142 5.400% | 2,214,142 (New Position) | Filing History |
| 2023-02-27 4:05 pm Purchase | 2023-02-16 | 13G | Ambrx Biopharma Inc. AMAM | Venrock Healthcare Capital Partners III L.P. | 26,740,000 9.900% | 26,740,000 (New Position) | Filing History |
| 2023-02-17 4:05 pm Purchase | 2023-02-07 | 13G | Avalo Therapeutics, Inc. AVTX | Venrock Healthcare Capital Partners III L.P. | 5,635 9.990% | 5,635 (New Position) | Filing History |
| 2023-02-14 4:30 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Venrock Healthcare Capital Partners III L.P. | 4,230,621 9.990% | 2,025,353 (+91.84%) | Filing History |